Annual D&A
$158.00 K
-$8000.00-4.82%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual depreciation & amortization is $158.00 thousand, with the most recent change of -$8000.00 (-4.82%) on December 31, 2023.
- During the last 3 years, AVTX annual D&A has fallen by -$1.69 million (-91.43%).
- AVTX annual D&A is now -96.53% below its all-time high of $4.55 million, reached on December 31, 2018.
Performance
AVTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$34.00 K
+$1000.00+3.03%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly depreciation & amortization is $34.00 thousand, with the most recent change of +$1000.00 (+3.03%) on September 30, 2024.
- Over the past year, AVTX quarterly D&A has increased by +$1000.00 (+3.03%).
- AVTX quarterly D&A is now -97.26% below its all-time high of $1.24 million, reached on June 30, 2018.
Performance
AVTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$144.00 K
-$7000.00-4.64%
September 30, 2024
Summary
- As of February 8, 2025, AVTX TTM depreciation & amortization is $144.00 thousand, with the most recent change of -$7000.00 (-4.64%) on September 30, 2024.
- Over the past year, AVTX TTM D&A has dropped by -$7000.00 (-4.64%).
- AVTX TTM D&A is now -96.89% below its all-time high of $4.63 million, reached on March 31, 2019.
Performance
AVTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
AVTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.8% | +3.0% | -4.6% |
| 3 y3 years | -91.4% | -2.9% | -13.3% |
| 5 y5 years | -96.5% | -96.8% | -13.3% |
AVTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.5% | at low | -88.5% | +13.3% | -91.3% | +9.1% |
| 5 y | 5-year | -95.9% | at low | -94.5% | +13.3% | -96.3% | +9.1% |
| alltime | all time | -96.5% | +690.0% | -97.3% | +529.6% | -96.9% | +2017.7% |
Avalo Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $34.00 K(+3.0%) | $144.00 K(-4.6%) |
| Jun 2024 | - | $33.00 K(-2.9%) | $151.00 K(-5.0%) |
| Mar 2024 | - | $34.00 K(-20.9%) | $159.00 K(+0.6%) |
| Dec 2023 | $158.00 K(-4.8%) | $43.00 K(+4.9%) | $158.00 K(+5.3%) |
| Sep 2023 | - | $41.00 K(0.0%) | $150.00 K(+4.9%) |
| Jun 2023 | - | $41.00 K(+24.2%) | $143.00 K(+8.3%) |
| Mar 2023 | - | $33.00 K(-5.7%) | $132.00 K(-20.5%) |
| Dec 2022 | $166.00 K(-90.0%) | $35.00 K(+2.9%) | $166.00 K(-61.0%) |
| Sep 2022 | - | $34.00 K(+13.3%) | $426.00 K(-49.7%) |
| Jun 2022 | - | $30.00 K(-55.2%) | $847.00 K(-33.5%) |
| Mar 2022 | - | $67.00 K(-77.3%) | $1.27 M(-23.2%) |
| Dec 2021 | $1.66 M(-10.1%) | $295.00 K(-35.2%) | $1.66 M(-12.8%) |
| Sep 2021 | - | $455.00 K(-0.2%) | $1.90 M(+1.5%) |
| Jun 2021 | - | $456.00 K(+1.1%) | $1.87 M(+1.6%) |
| Mar 2021 | - | $451.00 K(-16.2%) | $1.84 M(-0.1%) |
| Dec 2020 | $1.84 M(-52.5%) | $538.00 K(+26.3%) | $1.84 M(-4.1%) |
| Sep 2020 | - | $426.00 K(0.0%) | $1.92 M(-24.9%) |
| Jun 2020 | - | $426.00 K(-6.0%) | $2.56 M(-21.0%) |
| Mar 2020 | - | $453.00 K(-26.6%) | $3.24 M(-16.6%) |
| Dec 2019 | $3.88 M | $617.30 K(-41.9%) | $3.88 M(-13.5%) |
| Sep 2019 | - | $1.06 M(-3.8%) | $4.49 M(-0.2%) |
| Jun 2019 | - | $1.10 M(+0.6%) | $4.50 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $1.10 M(-10.1%) | $4.63 M(+1.7%) |
| Dec 2018 | $4.55 M(+970.5%) | $1.22 M(+14.1%) | $4.55 M(+21.7%) |
| Sep 2018 | - | $1.07 M(-13.6%) | $3.74 M(+39.8%) |
| Jun 2018 | - | $1.24 M(+21.2%) | $2.68 M(+85.5%) |
| Mar 2018 | - | $1.02 M(+150.5%) | $1.44 M(+239.1%) |
| Dec 2017 | $425.50 K(+1481.8%) | $408.40 K(+7463.0%) | $425.50 K(+1710.6%) |
| Sep 2017 | - | $5400.00(-8.5%) | $23.50 K(-6.7%) |
| Jun 2017 | - | $5900.00(+1.7%) | $25.20 K(-2.7%) |
| Mar 2017 | - | $5800.00(-9.4%) | $25.90 K(-3.7%) |
| Dec 2016 | $26.90 K(+14.5%) | $6400.00(-9.9%) | $26.90 K(+1.1%) |
| Sep 2016 | - | $7100.00(+7.6%) | $26.60 K(+3.1%) |
| Jun 2016 | - | $6600.00(-2.9%) | $25.80 K(+4.5%) |
| Mar 2016 | - | $6800.00(+11.5%) | $24.70 K(+5.6%) |
| Dec 2015 | $23.50 K(-18.7%) | $6100.00(-3.2%) | $23.40 K(-7.1%) |
| Sep 2015 | - | $6300.00(+14.5%) | $25.20 K(-4.2%) |
| Jun 2015 | - | $5500.00(0.0%) | $26.30 K(-4.7%) |
| Mar 2015 | - | $5500.00(-30.4%) | $27.60 K(-4.5%) |
| Dec 2014 | $28.90 K(+44.5%) | $7900.00(+6.8%) | $28.90 K(+37.6%) |
| Sep 2014 | - | $7400.00(+8.8%) | $21.00 K(+54.4%) |
| Jun 2014 | - | $6800.00(0.0%) | $13.60 K(+100.0%) |
| Mar 2014 | - | $6800.00 | $6800.00 |
| Dec 2013 | $20.00 K | - | - |
FAQ
- What is Avalo Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Avalo Therapeutics?
- What is Avalo Therapeutics annual D&A year-on-year change?
- What is Avalo Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly D&A year-on-year change?
- What is Avalo Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Avalo Therapeutics?
- What is Avalo Therapeutics TTM D&A year-on-year change?
What is Avalo Therapeutics annual depreciation & amortization?
The current annual D&A of AVTX is $158.00 K
What is the all time high annual D&A for Avalo Therapeutics?
Avalo Therapeutics all-time high annual depreciation & amortization is $4.55 M
What is Avalo Therapeutics annual D&A year-on-year change?
Over the past year, AVTX annual depreciation & amortization has changed by -$8000.00 (-4.82%)
What is Avalo Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of AVTX is $34.00 K
What is the all time high quarterly D&A for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly depreciation & amortization is $1.24 M
What is Avalo Therapeutics quarterly D&A year-on-year change?
Over the past year, AVTX quarterly depreciation & amortization has changed by +$1000.00 (+3.03%)
What is Avalo Therapeutics TTM depreciation & amortization?
The current TTM D&A of AVTX is $144.00 K
What is the all time high TTM D&A for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM depreciation & amortization is $4.63 M
What is Avalo Therapeutics TTM D&A year-on-year change?
Over the past year, AVTX TTM depreciation & amortization has changed by -$7000.00 (-4.64%)